UK NICE Review Will Look At Criteria For Appraising Highly Specialized Products
The UK's HTA body, NICE, says a more scientific criteria should be used to decide how many products should be admitted to its program for evaluating highly specialized technologies.
You may also be interested in...
A UK parliamentary report has called for the HTA body NICE to consider the use of conditional reimbursement recommendations and more flexible cost-effectiveness thresholds in its ongoing methods review.
Sir Andrew Dillon is leaving his role as CEO of England’s health technology assessment body after 20 years.
Sir Andrew Dillon is stepping down from what has been described as one of the most challenging and potentially controversial roles in British public life.